siha cl-0210 (Procell Inc)
90
Structured Review
Procell Inc
siha cl-0210
Siha Cl 0210, supplied by Procell Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/siha+cl-0210/siha+cells/pm39586885-28-7-12
Average 90 stars, based on 1 article reviews
Siha Cl 0210, supplied by Procell Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/siha+cl-0210/siha+cells/pm39586885-28-7-12
Average 90 stars, based on 1 article reviews
siha cl-0210 - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Cell Culture:Article Title: TBP activates DCBLD1 transcription to promote cell cycle progression in cervical cancer. Article Snippet: of high-risk HPV increases from 12% in normal cytology cases to 89% in CC cases (So et al. 2019).. Regrettably, the majority of patients with CC exhibit limited symptoms during the initial stages, leading to diagnosis at an advanced stage, which is often associated with an unfavorable prognosis and elevated mortality rates (Xin et al. 2022).. Given these insights, researchers and clinicians are facing ongoing challenges in exploring innovative and efficacious treatment approaches. Article Title: RGS1 and related genes as potential targets for immunotherapy in cervical cancer: computational biology and experimental validation Article Snippet: HeLa (CL-0101, Procell, China) and SiHa (CL-0210, Procell, China) were cultured in RPMI 1640 (SH30255.01, HyClone, USA) with 10% Knockdown:Article Title: TBP activates DCBLD1 transcription to promote cell cycle progression in cervical cancer. Article Snippet: of high-risk HPV increases from 12% in normal cytology cases to 89% in CC cases (So et al. 2019).. Regrettably, the majority of patients with CC exhibit limited symptoms during the initial stages, leading to diagnosis at an advanced stage, which is often associated with an unfavorable prognosis and elevated mortality rates (Xin et al. 2022).. Given these insights, researchers and clinicians are facing ongoing challenges in exploring innovative and efficacious treatment approaches. Article Title: RGS1 and related genes as potential targets for immunotherapy in cervical cancer: computational biology and experimental validation Article Snippet: HeLa (CL-0101, Procell, China) and SiHa (CL-0210, Procell, China) were cultured in RPMI 1640 (SH30255.01, HyClone, USA) with 10% Quantitative RT-PCR:Article Title: TBP activates DCBLD1 transcription to promote cell cycle progression in cervical cancer. Article Snippet: of high-risk HPV increases from 12% in normal cytology cases to 89% in CC cases (So et al. 2019).. Regrettably, the majority of patients with CC exhibit limited symptoms during the initial stages, leading to diagnosis at an advanced stage, which is often associated with an unfavorable prognosis and elevated mortality rates (Xin et al. 2022).. Given these insights, researchers and clinicians are facing ongoing challenges in exploring innovative and efficacious treatment approaches. Article Title: RGS1 and related genes as potential targets for immunotherapy in cervical cancer: computational biology and experimental validation Article Snippet: HeLa (CL-0101, Procell, China) and SiHa (CL-0210, Procell, China) were cultured in RPMI 1640 (SH30255.01, HyClone, USA) with 10% Expressing:Article Title: TBP activates DCBLD1 transcription to promote cell cycle progression in cervical cancer. Article Snippet: of high-risk HPV increases from 12% in normal cytology cases to 89% in CC cases (So et al. 2019).. Regrettably, the majority of patients with CC exhibit limited symptoms during the initial stages, leading to diagnosis at an advanced stage, which is often associated with an unfavorable prognosis and elevated mortality rates (Xin et al. 2022).. Given these insights, researchers and clinicians are facing ongoing challenges in exploring innovative and efficacious treatment approaches. Article Title: RGS1 and related genes as potential targets for immunotherapy in cervical cancer: computational biology and experimental validation Article Snippet: HeLa (CL-0101, Procell, China) and SiHa (CL-0210, Procell, China) were cultured in RPMI 1640 (SH30255.01, HyClone, USA) with 10% Western Blot:Article Title: TBP activates DCBLD1 transcription to promote cell cycle progression in cervical cancer. Article Snippet: of high-risk HPV increases from 12% in normal cytology cases to 89% in CC cases (So et al. 2019).. Regrettably, the majority of patients with CC exhibit limited symptoms during the initial stages, leading to diagnosis at an advanced stage, which is often associated with an unfavorable prognosis and elevated mortality rates (Xin et al. 2022).. Given these insights, researchers and clinicians are facing ongoing challenges in exploring innovative and efficacious treatment approaches. Article Title: RGS1 and related genes as potential targets for immunotherapy in cervical cancer: computational biology and experimental validation Article Snippet: HeLa (CL-0101, Procell, China) and SiHa (CL-0210, Procell, China) were cultured in RPMI 1640 (SH30255.01, HyClone, USA) with 10% Migration:Article Title: TBP activates DCBLD1 transcription to promote cell cycle progression in cervical cancer. Article Snippet: of high-risk HPV increases from 12% in normal cytology cases to 89% in CC cases (So et al. 2019).. Regrettably, the majority of patients with CC exhibit limited symptoms during the initial stages, leading to diagnosis at an advanced stage, which is often associated with an unfavorable prognosis and elevated mortality rates (Xin et al. 2022).. Given these insights, researchers and clinicians are facing ongoing challenges in exploring innovative and efficacious treatment approaches. Article Title: RGS1 and related genes as potential targets for immunotherapy in cervical cancer: computational biology and experimental validation Article Snippet: HeLa (CL-0101, Procell, China) and SiHa (CL-0210, Procell, China) were cultured in RPMI 1640 (SH30255.01, HyClone, USA) with 10% Immunofluorescence:Article Title: TBP activates DCBLD1 transcription to promote cell cycle progression in cervical cancer. Article Snippet: of high-risk HPV increases from 12% in normal cytology cases to 89% in CC cases (So et al. 2019).. Regrettably, the majority of patients with CC exhibit limited symptoms during the initial stages, leading to diagnosis at an advanced stage, which is often associated with an unfavorable prognosis and elevated mortality rates (Xin et al. 2022).. Given these insights, researchers and clinicians are facing ongoing challenges in exploring innovative and efficacious treatment approaches. Article Title: RGS1 and related genes as potential targets for immunotherapy in cervical cancer: computational biology and experimental validation Article Snippet: HeLa (CL-0101, Procell, China) and SiHa (CL-0210, Procell, China) were cultured in RPMI 1640 (SH30255.01, HyClone, USA) with 10% |
